Acadian Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Acadian Asset Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-409,183	Closed	-$7.58M	–	1876
2023 Q3	$7.58M	Buy	409,183 +128,622	+46%	+$1.45M	0.03%	339
2023 Q2	$3.1M	Sell	280,561 -129,032	-32%	-$1.8M	0.01%	575
2023 Q1	$5.5M	Buy	409,593 +17,740	+5%	+$307K	0.02%	437
2022 Q4	$4.84M	Buy	391,853 +291,417	+290%	+$4.13M	0.02%	453
2022 Q3	$1.4M	Buy	100,436 +91,733	+1,054%	+$1.48M	0.01%	720
2022 Q2	$120K	Sell	8,703 -101,110	-92%	-$1.62M	﹤0.01%	1322
2022 Q1	$1.78M	Sell	109,813 -16,419	-13%	-$257K	0.01%	694
2021 Q4	$2.06M	Buy	+126,232	New	+$2.13M	0.01%	649
2021 Q3	–	Sell	-60,136	Closed	-$1.2M	–	2092
2021 Q2	$1.2M	Buy	+60,136	New	+$1.19M	﹤0.01%	859
2021 Q1	–	Sell	-2,484	Closed	-$61K	–	2383
2020 Q4	$61K	Buy	+2,484	New	+$82.3K	﹤0.01%	1890

Acadian Asset Management's ICPT Position: Q4 2023 in Review

Acadian Asset Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 409,183 shares — an estimated $7.58M sold.

Acadian Asset Management first reported a position in ICPT in Q4 2020 and held it in 10 quarters. The position peaked at $7.58M in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

Acadian Asset Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
Acadian Asset Management sold 409,183 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $7.58M.
Acadian Asset Management first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2020 and held it in 10 quarters.
Acadian Asset Management's Intercept Pharmaceuticals, Inc. position peaked at $7.58M in Q3 2023.
0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Acadian Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.